Stock target detail
Amgen Inc.
AMGN · Healthcare · data refresh Nov 21, 2026
Current price$435.64
Average target$437.01
Upside to average+0.3%
Analyst opinions29
Target range & consensus
Published analyst targets span a range; the average is not a price forecast.
Median target$440.00
Low target$230.00
High target$542.00
Next earningsNov 3, 2026
Strong Buy 4 · Buy 7 · Hold 18 · Sell 5
Recent target changes
Date, firm, previous target, new target, and change only.
| Stock | Firm | Date | Previous | New target | Change |
|---|---|---|---|---|---|
| AMGNAmgen Inc. | HSBC | Sep 10 | $445.00 | $425.00 | -4.5% |
| AMGNAmgen Inc. | BMO Capital | Sep 8 | $450.00 | $450.00 | 0.0% |
| AMGNAmgen Inc. | Cantor Fitzgerald | Sep 8 | $400.00 | $400.00 | 0.0% |
| AMGNAmgen Inc. | Wells Fargo | Sep 4 | $400.00 | $435.00 | +8.8% |
| AMGNAmgen Inc. | Piper Sandler | Aug 20 | $427.00 | $457.00 | +7.0% |
| AMGNAmgen Inc. | Morgan Stanley | Aug 19 | $351.00 | $362.00 | +3.1% |
| AMGNAmgen Inc. | Argus Research | Aug 19 | $375.00 | $460.00 | +22.7% |
| AMGNAmgen Inc. | Mizuho | Aug 18 | $303.00 | $352.00 | +16.2% |
| AMGNAmgen Inc. | Cantor Fitzgerald | Aug 18 | $350.00 | $400.00 | +14.3% |
| AMGNAmgen Inc. | Barclays | Aug 14 | $360.00 | $380.00 | +5.6% |
| AMGNAmgen Inc. | Guggenheim | Aug 10 | $343.00 | $388.00 | +13.1% |
| AMGNAmgen Inc. | Citigroup | Aug 7 | $345.00 | $405.00 | +17.4% |
| AMGNAmgen Inc. | Bernstein | Aug 6 | $335.00 | $345.00 | +3.0% |
| AMGNAmgen Inc. | Baird | Aug 5 | $215.00 | $230.00 | +7.0% |
| AMGNAmgen Inc. | Canaccord Genuity | Aug 5 | $366.00 | $384.00 | +4.9% |
| AMGNAmgen Inc. | B of A Securities | Aug 5 | $312.00 | $317.00 | +1.6% |
| AMGNAmgen Inc. | Goldman Sachs | Aug 5 | $427.00 | $450.00 | +5.4% |
| AMGNAmgen Inc. | UBS | Aug 5 | $420.00 | $440.00 | +4.8% |
| AMGNAmgen Inc. | Morgan Stanley | Aug 5 | $333.00 | $351.00 | +5.4% |
| AMGNAmgen Inc. | TD Cowen | Aug 5 | $420.00 | $452.00 | +7.6% |
| AMGNAmgen Inc. | Truist Securities | Aug 5 | $340.00 | $362.00 | +6.5% |
| AMGNAmgen Inc. | Oppenheimer | Aug 5 | $400.00 | $450.00 | +12.5% |
| AMGNAmgen Inc. | Scotiabank | Aug 5 | $385.00 | $450.00 | +16.9% |
| AMGNAmgen Inc. | RBC Capital | Aug 5 | $370.00 | $400.00 | +8.1% |
| AMGNAmgen Inc. | Wells Fargo | Aug 5 | $390.00 | $400.00 | +2.6% |
| AMGNAmgen Inc. | BMO Capital | Aug 5 | $400.00 | $450.00 | +12.5% |
| AMGNAmgen Inc. | Barclays | Jul 29 | $350.00 | $360.00 | +2.9% |
| AMGNAmgen Inc. | B of A Securities | Jul 13 | $307.00 | $312.00 | +1.6% |
| AMGNAmgen Inc. | UBS | Jul 13 | $400.00 | $420.00 | +5.0% |
| AMGNAmgen Inc. | Guggenheim | Jul 13 | $340.00 | $343.00 | +0.9% |
| AMGNAmgen Inc. | Morgan Stanley | Jul 8 | $340.00 | $333.00 | -2.1% |
| AMGNAmgen Inc. | Truist Securities | Jul 7 | $327.00 | $340.00 | +4.0% |
| AMGNAmgen Inc. | Cantor Fitzgerald | Jul 6 | $350.00 | $350.00 | 0.0% |
| AMGNAmgen Inc. | Mizuho | Jun 16 | $295.00 | $303.00 | +2.7% |
| AMGNAmgen Inc. | Morgan Stanley | Jun 10 | $332.00 | $340.00 | +2.4% |
| AMGNAmgen Inc. | Argus Research | May 20 | $400.00 | $375.00 | -6.3% |
| AMGNAmgen Inc. | Piper Sandler | May 14 | $432.00 | $427.00 | -1.2% |
| AMGNAmgen Inc. | Guggenheim | May 4 | $351.00 | $340.00 | -3.1% |
| AMGNAmgen Inc. | Truist Securities | May 1 | $325.00 | $327.00 | +0.6% |
| AMGNAmgen Inc. | Canaccord Genuity | Apr 21 | — | $366.00 | Announces |
How to read this page
Analyst target prices are estimates made by individual research firms. They may change after earnings, industry developments, or changes to the analyst's assumptions. Target Signal shows the reported consensus and changes for research purposes only.
Data limitations
Data can be delayed, incomplete, and revised by its source. Do not make an investment decision using this page alone.